-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
August 09, 2021 - of PBI, such as larger tumor size (2-3 cm), high tumor grade, close margins, human
epidermal growth factor … of Cancer Therapy-
Breast; EQD2 = Equivalent Dose in 2 Gy fractions; HER2 = human epidermal growth factor … Draft analytic framework
Abbreviations: CQ = contextual question; HER2 = human epidermal growth factor … Practice Center
FACT-B Functional Assessment of Cancer Therapy-Breast
HER2 Human Epidermal Grow th Factor … Abbreviations: CQ = contextual question; HER2 = human epidermal growth factor receptor 2; KQ = key question
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicine-safety-call-center_research.pdf
September 01, 2007 - 2000) report that independent collection of reports and analysis
by peer evaluation is an important factor … As such, financial incentives can serve an additional factor in
promoting the adoption of a community-pharmacy … Success Factor Implementation Possible IT Solutions
Immunity Anonymity of reporters,
participants … Services for
heterogeneous data and
IT Architecture for Post-Marketing Surveillance
22
Success Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - 2000) report that independent collection of reports and analysis
by peer evaluation is an important factor … As such, financial incentives can serve an additional factor in
promoting the adoption of a community-pharmacy … Success Factor Implementation Possible IT Solutions
Immunity Anonymity of reporters,
participants … Services for
heterogeneous data and
IT Architecture for Post-Marketing Surveillance
22
Success Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-learning-objectives-recommendations.pdf
July 01, 2019 - method, the Mantel-Haenszel method,
or a logistic regression approach, without adding a correction factor … under
consideration of low power associated with limited studies (i.e., <10 studies per study-level
factor
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
November 03, 2020 - Yes, we (and the included multivariable
analyses) treat each risk factor as
independent. … Regarding tobacco use, the risk factor is not
starting tobacco use, but instead current
tobacco use … There are only a
handful, and this is the limiting factor.
Thank you
Peer Reviewer 1 e. … Each factor is set
out in turn and gaps are adequately described. … AHRQ’s list of risk factors for overdose and death
ignores this important factor.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
November 03, 2011 - : Humans, Clinical Trial, Randomized Controlled Trial, English
Search "Brain-Derived Neurotrophic Factor … Humans, Clinical Trial,
Randomized Controlled Trial, English
Search "Brain-Derived Neurotrophic Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
January 30, 2012 - sample size of ~50,000 subjects:
• Re-LY, with approximately 18,000 subjects and the new direct factor … Engl J Med 2009;361(12):1139-5122)
• ROCKET AF, with approximately 14,000 subjects and the new direct factor … Heart J 2010;159(3):340-723])
• ARISTOTLE, with approximately 14,000 subjects and the new direct factor … Rivaroxaban-once daily, oral, direct factor Xa inhibition
compared with vitamin K antagonism for prevention
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - Older age is an
important independent risk factor for delirium,2 with a prevalence >70% in critically … A 2018 systematic review reported that delirium duration is the modifiable
factor most strongly associated … Delirium is a strong risk factor for
dementia in the oldest-old: a population-based cohort study.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Elevated serum uric
acid (sUA) levels are thought to be the most important risk factor for the development … and Allopurinol-Refractory Gout
Key Facts: Hyperuricemia is believed to be the most important risk factor … Allopurinol-Refractory Gout
Intervention: Hyperuricemia is thought to be the most important risk factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - BP=Blood Pressure;
CHF=Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor … 26-39
kg/m2)
Renal function,
inflammatory profile
(MCP-1) and macrophage
migration inhibitory factor … stage 2 patients
decreased urinary albumin, N-acetyl B-D-
glucosaminidase and transforming growth
factor … Beta-trace protein; CHF=Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor … Improving Global Outcomes; LSD=Low Sodium Diet; MI=Myocardial Infarction; MIF=Migration
Inhibitory Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/suppl-1-user-guide-to-ocer_130129.pdf
January 01, 2011 - An instrument is a measured factor
related to treatment choice, but assumed not
to have a direct relationship … For each factor
“X
i
”, distinctions are made for measured (X
iM
) and
unmeasured (X
iU
) factors
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - therapy
suggest an immunologic nature of the disease.
8,9
Various cytokines, like tumor necrosis factor … Food and Drug Administration; IL = interleukin; TNF = tumor necrosis factor
Source: www.effectivehealthcare.ahrq.gov … leukemia; CVP=cyclophosphamide,
vincristine, and prednisolone chemotherapy; EGFR = epidermal growth factor … receptor; NHL=non-Hodgkin’s lymphoma; TNF=tumor necrosis factor
Source: www.effectivehealthcare.ahrq.gov … monoclonal antibody.mp. or Antibodies, Monoclonal/
37. t-cell modulator.mp.
38. tumor necrosis factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - In addition to being the primary
attributable risk factor for death throughout
the world, hypertension … Risk factor reduction and Lipid levels, There were no consistent differential effects of ACEIs, ARBs,
-
effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
January 01, 2013 - Confounding arises when a risk factor for the study outcome of interest directly or indirectly affects … Comparator Choice (1 of 2)
Consequences of Comparator Choice (1 of 2)
Confounding arises when a risk factor … metabolic effects of antipsychotic drugs, body mass index is a potential confounder because it is a risk factor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - remain unbiased even if important confounding variables were
unmeasured.28,29,30 An IV is an observable factor … unmeasured
confounder.*
0
2
4
6
8
10
0 2 4 6 8 10
RRCD
O
R
E
C
ARR=1.35
ARR=1.26
* Any factor … (a single factor or combination of multiple factors) that has a combination of RRCD and OREC values
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
November 29, 2023 - bone benefits are thought to stem from
1) its ability to increase secretion of insulin-like growth factor … a normal adaptive function of the kidney, and that this adaptive response does not
present a risk factor … Assessment, Development and Evaluation
HKSJ Hartung, Knapp, Sidik, and Jonkman
IGF 1 Insulin-like Growth Factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
September 01, 2014 - method, these groups were treated together as
‘multiple methods’ in statistical analyses for that factor … complementary
sources: (1) within-study evidence (i.e., comparisons of
test performance over levels of a factor … Twenty studies provided information that allowed an
evaluation of the impact of any factor on test performance … within-study analyses and meta-regression
analyses were insufficient to confirm (or exclude) any
single factor … needle biopsy did
not allow investigation of the impact of factors on adverse
events and no individual factor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
August 23, 2013 - Thank you
Peer Reviewer
#2
General Throughout the report, the authors use the terms
“Factor II” … To be
correct, the authors should know that Factor II is
PROthrombin and Factor IIa is THROMBIN. … NONE of these scores includes chronic kidney
disease which is an established risk factor for stroke … Aspirin is a well-
established risk factor for hemorrhage but it would
be unavailable in population … The section of the report evaluating outcomes
associated with Factor Xa Inhibitors and warfarin
does
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-di
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - patients with possible lung cancer, key clinical inputs include symptom
assessment, clinical exam, risk factor … characteristics (KQ3), the study must
have reported comparative accuracy data stratified by patient/tumor factor … , or
comparative effectiveness data stratified by patient/tumor factor. … factors and tumor characteristics, we will calculate for
each study the association between a patient factor … This factor is used for studies of treatments, and is not
relevant for this topic.